About Institute for clinical and economic review
The Institute for Clinical and Economic Review (ICER) is a non-profit organization that provides independent evaluations on the value of medical tests, treatments, and delivery systems. ICER's mission is to improve patient outcomes by providing objective evidence-based information to patients, clinicians, insurers, and policymakers.
ICER was founded in 2006 with the goal of improving the quality and affordability of healthcare in the United States. The organization conducts rigorous assessments of new drugs and medical technologies to determine their clinical effectiveness, cost-effectiveness, and overall value to patients.
One of ICER's primary activities is conducting cost-effectiveness analyses (CEAs) on new drugs. CEAs are used to evaluate whether a drug provides good value for money compared to other treatments or interventions. ICER uses a variety of methods to conduct CEAs including decision-analytic modeling, systematic reviews of clinical evidence, and economic modeling.
In addition to conducting CEAs on new drugs, ICER also evaluates existing treatments and delivery systems. For example, ICER has conducted evaluations on the use of opioids for chronic pain management as well as alternative payment models for cancer care.
ICER's evaluations are widely respected by healthcare stakeholders including patient advocacy groups, clinicians, insurers, and policymakers. The organization has been recognized by numerous organizations including the National Academy for State Health Policy (NASHP), which awarded ICER its 2019 Impact Award.
One reason why ICER's evaluations are so highly regarded is because they are conducted independently from industry influence. Unlike many other organizations that evaluate medical technologies or provide treatment guidelines based on input from industry-sponsored panels or committees with conflicts-of-interests; all members involved in an evaluation at ICER must disclose any potential conflicts-of-interests before participating in an evaluation process.
Another reason why ICER's evaluations are so valuable is because they provide transparent information about how decisions were made regarding which studies were included/excluded from analysis; what assumptions were made about costs/clinical outcomes; how uncertainties were addressed; etc., making it easier for stakeholders such as payers or providers who may not have expertise in health economics research methods but need reliable information when making decisions about coverage policies or treatment recommendations
Overall if you're looking for unbiased assessments regarding medical tests/treatments/delivery systems then look no further than Institute For Clinical And Economic Review!
icer-review.org
